Prognostic and therapeutic implications of <i>BRAF</i> mutations in acute myeloid leukemia
Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02996-1Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia
Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02996-1Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia

Leukemia, Published online: 11 June 2026; doi:10.1038/s41375-026-03002-4Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and ni

Leukemia, Published online: 10 June 2026; doi:10.1038/s41375-026-02987-2Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analy

Leukemia, Published online: 10 June 2026; doi:10.1038/s41375-026-02990-7Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report

Leukemia, Published online: 09 June 2026; doi:10.1038/s41375-026-03000-6Organelle proteomics reveals novel metabolic vulnerabilities in FLT3-ITD cells

Leukemia, Published online: 03 June 2026; doi:10.1038/s41375-026-02997-0Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia